IPO Wrap: 2024 outlook for IPOs, and which stocks could list on ASX before year-end
IPO Watch
IPO Watch
The global IPO market landscape shifted in 2023, with volumes falling by 8% and proceeds down by 33% compared with 2022, according to a report from E&Y.
Despite the strong equity market rally this year (S&P 500 up 24% and ASX200 up 7%), IPOs have remained muted in many developed markets.
The exception was the month of September, when a flurry of top names such as ARM Holdings, Instacart, and Klaviyo went public.
E&Y believes that in 2024, enthusiasm for IPOs will be high, and smaller deals will emerge as market sentiment improves.
The consulting company, however, adds that potential candidates should monitor the macro situation carefully.
“Before monetary policy eases and geopolitical climate stabilises, IPO candidates should keep their eyes on building fundamentals and managing price expectations to capitalise on the fleeting windows as 2024 progresses,” said E&Y.
Globally, E&Y believes moderating inflation and potential 2024 interest rate cuts could attract investors back to IPOs.
“However, sustained geopolitical instability may undermine confidence. Broadly, the year ahead hinges on an improving macroeconomic backdrop for IPO revival, as companies eagerly await more favourable market conditions to widen IPO windows.”
IPO candidates looking to go public in 2024 will also need to be well-prepared.
“Key factors to consider are: inflation and interest rates, government policies and regulations, recovery of economic activities, geopolitical tensions and conflicts, ESG agenda, and global supply chain,” said E&Y.
Swipe or scroll to reveal the full table. Click headings to sort.
Code | Name | IPO Price | Current Price | Return | Market cap | Listing date |
---|---|---|---|---|---|---|
GHY | Gold Hydrogen | 0.5 | 0.955 | 91% | $73,213,187 | 13/1/2023 |
GDM | Great Divide Mining | 0.2 | 0.300 | 50% | $8,175,000 | 18/10/2023 |
JBY | James Bay Minerals | 0.2 | 0.285 | 43% | $9,246,825 | 12/9/2023 |
CC9 | Chariot Corp | 0.45 | 0.590 | 31% | $43,265,625 | 30/10/2023 |
GR8 | Great Dirt Resources | 0.2 | 0.220 | 10% | $6,190,527 | 10/11/2023 |
TOK | Tolu Minerals | 0.5 | 0.500 | 0% | $29,380,422 | 10/11/2023 |
NDO | Nido Education | 1 | 0.980 | -2% | $216,660,943 | 16/10/2023 |
PLN | Pioneer Lithium | 0.2 | 0.190 | -5% | $5,400,750 | 28/9/2023 |
RDX | Redox | 2.55 | 2.390 | -6% | $1,254,944,613 | 3/7/2023 |
HTM | High-Tech Metals | 0.2 | 0.175 | -13% | $4,331,510 | 23/1/2023 |
CHW | Chilwaminerals | 0.2 | 0.170 | -15% | $7,798,750 | 5/7/2023 |
COV | Cleo Diagnostics | 0.2 | 0.170 | -15% | $12,597,000 | 22/8/2023 |
ASK | Abacus Storage King | 1.41 | 1.130 | -20% | $1,484,936,347 | 1/8/2023 |
FCG | Freedom Care Group | 0.2 | 0.155 | -23% | $3,702,006 | 30/11/2023 |
NVO | Novo Resources Corp | 0.2 | 0.150 | -25% | $6,740,720 | 11/9/2023 |
EG1 | Evergreen Lithium | 0.25 | 0.185 | -26% | $10,402,550 | 11/4/2023 |
DYM | Dynamic Metals | 0.2 | 0.140 | -30% | $4,900,000 | 16/1/2023 |
ILT | Iltani Resources | 0.2 | 0.140 | -30% | $4,761,471 | 30/6/2023 |
CVB | Curvebeam Ai | 0.48 | 0.335 | -30% | $67,919,814 | 23/8/2023 |
NGX | NGX | 0.2 | 0.135 | -33% | $12,232,598 | 16/6/2023 |
CGR | CGN Resources | 0.25 | 0.165 | -34% | $14,978,402 | 18/10/2023 |
ACM | Aus Critical Mineral | 0.2 | 0.120 | -40% | $3,849,150 | 3/7/2023 |
SQX | SQX Resources | 0.2 | 0.115 | -43% | $2,875,000 | 20/2/2023 |
AUG | Augustus Minerals | 0.2 | 0.115 | -43% | $9,673,800 | 25/5/2023 |
PL3 | Patagonia Lithium | 0.2 | 0.110 | -45% | $5,404,135 | 31/3/2023 |
LM1 | Leeuwin Metals | 0.25 | 0.135 | -46% | $6,212,110 | 29/3/2023 |
VHM | VHM | 1.35 | 0.700 | -48% | $107,741,288 | 9/1/2023 |
DY6 | Dy6 Metals | 0.2 | 0.100 | -50% | $3,856,249 | 29/6/2023 |
ADC | Acdc Metals | 0.2 | 0.068 | -66% | $3,204,330 | 17/1/2023 |
ENL | Enlitic CDI | 0.83 | 0.850 | 2% | 75000000 | 19/12/2023 |
ACE | Acusensus | 4 | 0.780 | -81% | $98,591,981 | 12/1/2023 |
*Note: there was a 5:1 stock split for ACE
Health tech company, Enlitic Inc (ASX:ENL), made its ASX debut yesterday, closing at 85c vs IPO price of 83c.
Enlitic harnesses AI to manage medical imaging data in radiology, such as MRI, CT, X-ray and ultrasound images.
The Enlitic platform standardises, protects, and analyses data to create a database that improves clinical workflows, increases efficiencies, and expands capacity.
The company says it owns the industry’s first localised real-world medical imaging database that unlocks the value of historical diagnostic images, aligned with real-time diagnostics, and linkage to real-world data across any critical care solutions.
Health care providers using the Enlitic platform would have their productivity increased, and have their costs decreased, says the company.
Meanwhile, the best IPO this year was Gold Hydrogen (ASX:GHY), with a return of over 90%.
The stock has been rising since early November after the company announced that significant concentrations of hydrogen and helium were encountered in sections of the Ramsay 1 well, demonstrating an active hydrogen system in the Ramsay Project area.
In early December, Gold Hydrogen reported that Ramsay 2 well exploration has been completed, and that high helium concentrations were found, reaching up to 6.8% in raw gas from the Kulpara Formation.
Despite being only the second well in the company’s exploration program, multiple data points throughout the drilling campaign indicate the potential for a significant helium reservoir and a prolific helium system at the Ramsay project site.
Subsequent exploration, analysis and future flow testing will provide a clearer picture of this promising opportunity, the company said.
US-based lithium explorer Chariot Corp (ASX:CC9) has also been rising since announcing in early November that a drill rig has arrived at its flagship Black Mountain Project in Wyoming, US, ready for drilling.
Drilling operations are ongoing, with the first round of assay results expected in January 2024.
The Phase 1 drill program was designed to test the central portion of the Black Mountain pegmatite dike swarm, comprising a 1,000m long by +100m wide zone of LCT pegmatite sub-crop and outcrop.
All dates are sourced from the ASX website. They could change without notice.
Expected listing: December 21
IPO: $50m at $1.47 a share
Brazilian Rare Earths owns and operates a district scale Tier 1 Rare Earths Province, located in the the state of Bahia, North Eastern Brazil.
The company believes its resource – comparable to the world’s biggest non-Chinese rare earth clay project at Serra Verde – will potentially translate into multibillion-tonnes.
The flagship 510Mt Rocha de Rocha rare earths project represents one of the most exciting critical minerals discoveries globally. Grades of over 40% TREO have been found, with mineralisation at or near surface.
The project is also accessible by sealed roads, has access to clean hydropower via existing high-voltage power lines, and is located <200km from a major deep-water port.
Expected listing: December 22
IPO: Non-IPO. Merger between Allkem and Livent
In May, lithium giant Allkem (ASX:AKE) and US-based Livent announced an agreement to combine in an all-stock merger of equals to create a global integrated lithium chemicals producer.
The merger has won support from Livent’s big US pension fund shareholder and Allkem’s shareholders.
The merged company will be re-badged as Arcadium Lithium, and run by Livent CEO Paul Graves.
The company will also be 56-44 split between the holders of Allkem and Livent, with plans to become the world’s third largest lithium producer by 2028 behind Albemarle and SQM.
Its global portfolio, which will include Mt Cattlin, the Olaroz, El Fenix, Sal de Vida and Cauchari brines in Argentina, James Bay and Whabouchi hard rock mines in Quebec and Naraha lithium hydroxide plant in Japan, will eventually produce 248,000t of lithium carbonate equivalent tonnes a year.
Read more about LTM here: Allkem flags growth over dividends ahead of Livent merger
Expected listing: January 4 2024
IPO: $15m at $0.25 a share
Kali Metals was established from the spinout of a portfolio of lithium assets owned by ASX-listed Kalamazoo Resources (ASX:KZR), with assets in the Lachlan Fold Belt.
The Lachlan Fold Belt is best known for its copper, gold and silver production.
But it has also become a focus of lithium explorers, with juniors hoping to repeat the success of their west coast counterparts in WA.
Two of those projects have been sitting in the portfolio of Kalamazoo – the Jingellic and Tallangatta.
Both have now been turned into a new company called Kali Metals, along with KZR’s DOM’s Hill and Marble Bar projects in the Pilbara and the lithium rights at Karora Resources’ Higginsville tenement package in WA.
KZR will own 55% of the entity, which will see Graeme Sloan as MD and Luke Reinehr as chairman.